开发机器学习模型,用于预测当前和未来的痴呆症
Wonseok Jeong1, Wankyo Chung1,2
1Department of Public Health Sciences, Graduate School of Public Health, Seoul National University, Gwanak-gu, Seoul, Republic of Korea.
PloS one
|December 10, 2025
概括
机器学习模型只使用非临床数据准确预测痴呆症. 这种利用人口,社会经济和健康因素的方法,为早期痴呆症检测和预防策略提供了有前途的工具.
科学领域:
- 老年学与公共卫生
- 医疗保健中的人工智能
- 神经科学与衰老问题
背景情况:
- 痴呆症是一个重大的全球健康挑战,特别是在老年人群中.
- 目前对痴呆症的治疗方法有限,这强调了早期诊断对疾病管理的重要性.
- 现有的机器学习模型用于痴呆症预测,通常依赖于临床数据或缺乏概括性.
研究的目的:
- 开发和评估用于预测当前和未来痴呆症的机器学习模型.
- 仅使用人口,社会经济和健康相关特征进行痴呆症预测.
- 提高模型的透明度,并确定痴呆的主要风险因素.
主要方法:
- 机器学习算法应用于来自韩国长度老化研究 (KLoSA) 的数据.
- 功能选择采用了领域知识和统计测试策略.
- 模型性能通过交叉验证的网格搜索进行了优化,并在单独的测试集上进行了评估.
- 为了模型的可解释性,使用了SHAP (夏普利添加式扩展).
主要成果:
- 线性支向量机 (SVM) 和辐射偏差函数SVM在预测当前 (79.4%) 和未来 (77.7%) 痴呆症方面表现出高灵敏度.
- 这些模型仅使用非临床特征实现了合理准确的痴呆症预测.
- 根据SHAP方法,确定了与痴呆风险增加最强相关的十大特征.
结论:
- 非临床特征,包括人口,社会经济和健康相关的变量,对于预测痴呆症是有效的.
- 基于这些特征的机器学习模型为基于临床参数的模型提供了可行的替代方案.
- 这种方法具有早期痴呆症检测和干预的潜力,有助于疾病进展管理.
相关概念视频
01:30Dementia
486
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
486
01:22Alzheimer's Disease: Treatment
752
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
752
01:26Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K